(Q45220875)

English

An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys

scientific article published in December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nelly Mauras

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Susan Welch

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Annie Rini

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Karen Oerter Klein

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Journal of Pediatric Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1597-1606

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Growth hormone and sex steroids. Interactions in puberty

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Adult height in precocious puberty after long-term treatment with deslorelin

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Regional and total body bone mineral content, bone mineral density, and total body tissue composition in children 8-16 years of age.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2004.17.12.1597

21 January 2018

Identifiers

10.1515/JPEM.2004.17.12.1597

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45220875&oldid=2070444086"